Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Robinhood Markets, Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Robinhood Markets, Inc. trades at $108.66 (market cap $98.46B). The key difference: Robinhood Markets, Inc. is far larger — about 20.9× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Robinhood Markets, Inc. for 75 Days on average.
| DFTX | HOOD | |
|---|---|---|
Market Cap | $4.71B | $98.46B |
Volume | 1,966,636 | 18,771,023 |
Sector | Health | Financials |
52-Week High | $48.45 | $152.46 |
52-Week Low | $10.68 | $65.16 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $3.67B | $105.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Robinhood (HOOD) trades at $107.01, down 4.46% today, with a bullish technical signal and strong support at $105. The company reported robust revenue growth to $4.47B in 2025, with a net income margin of 42.01%, though valuation ratios like P/E of 48.46 are elevated. Recent news highlights expansion into 24/7 stock trading and AI-driven features, signaling innovation.
Outlook is positive with a consensus price target of $137, implying 28% upside, driven by product launches and market share gains. Risks include high valuation sensitivity and regulatory scrutiny over new offerings. Analyst sentiment is strongly bullish (77% buy ratings), but investors should monitor execution amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
